An ADAM17-Binding Antibody (MEDI-1) Enhances Proliferation of NK Cells from Multiple Myeloma Patients and Improves Killing with a B7-H3 Tri-Specific Killer Engager (TriKE)
Transplantation and Cellular Therapy（2023）
关键词
nk cells,multiple myeloma patients,multiple myeloma,antibody,tri-specific
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要